Experimental drug aims to clean out clogged hearts
NCT ID NCT07448623
Summary
This early study is testing a new drug called coramitug in people with ATTR-CM, a serious heart condition caused by abnormal protein clumps. Researchers want to see if coramitug can help remove these harmful protein deposits from the heart and prevent new ones from forming. They'll use special imaging scans to track where the drug goes in the body and measure its effects on the heart over about 3 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN AMYLOID CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ICON - location Groningen
Groningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.